Released: March 27, 2017
Defense Health Program
Department of Defense Tick-Borne Disease Research Program
Anticipated Funding Opportunities for Fiscal Year 2017
Due to the current Continuing Resolution, the Fiscal Year 2017 (FY17) Defense Appropriations bill has not been passed. Although funds have not been appropriated for the Department of Defense Tick-Borne Disease Research Program (TBDRP), the TBDRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY17 funding opportunities.
FY17 TBDRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on Grants.gov in May 2017. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the Government, and funding of research projects received in response to these Program Announcements is contingent on the availability of Federal funds appropriated for the TBDRP.
As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA), J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).
Applications submitted to the FY17 TBDRP must address at least one of the following specific Focus Areas in Lyme disease and other tick-borne diseases:
- Direct detection of agents of Lyme disease and other tick-borne diseases or their products in humans
- Biomarkers for diagnosis, prognosis, and cure
- Mechanisms of persistence of Lyme disease
- Host-pathogen interactions
- New research tools to support studies of pathogenesis
- Innovative approaches to treatment
- Studies aimed at safe and effective treatments for the cause(s) of persistent symptoms in Lyme disease
- Interrupting the cycle of the disease agents in nature
|Award Mechanism||Eligibility||Key Mechanism Elements||Funding|
|Investigator-Initiated Research Award||Independent investigators at or above the level of Associate Professor (or equivalent).||
|Idea Award||Established Investigators: Independent investigators at or above the level of Associate Professor (or equivalent); or
Investigators that meet the following criteria at the application submission deadline date:
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Applications must be submitted through the federal government’s single-entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the TBDRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
CDMRP Public Affairs
Last updated Monday, March 27, 2017